Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LEI-101 is a potent, selective, and orally bioavailable cannabinoid CB2 receptor agonist, with a pEC 50 of 8 for hCB2, and a pK i of less than 4 for hERG. LEI-101 is ~100-fold more potent in binding to CB2 receptors than to CB1 receptors. LEI-101 has therapeutic potential in diseases that are associated with inflammation and/or oxidative stress, including kidney disease [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | LEI-101 is a potent, selective, and orally bioavailable cannabinoid CB2 receptor agonist, with a pEC 50 of 8 for hCB2, and a pK i of less than 4 for hERG. LEI-101 is ~100-fold more potent in binding to CB2 receptors than to CB1 receptors. LEI-101 has therapeutic potential in diseases that are associated with inflammation and/or oxidative stress, including kidney disease [1] [2]. |
Molecular Weight | 472.53 |
Formula | C23H25FN4O4S |
CAS No. | 1228660-00-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LEI-101 1228660-00-1 LEI 101 LEI101 inhibitor inhibit